Emerging Data with Antiangiogenic Therapies in Early and Advanced Non–Small-Cell Lung Cancer

od Horn, Leora, Sandler, Alan B.
Izdano 2009

Angiogenesis in the Treatment of Non–Small Cell Lung Cancer

od Horn, Leora, Sandler, Alan B.
izdano v Proc Am Thorac Soc (2009)

The Role of MET Receptor Tyrosine Kinase in Non-Small Cell Lung Cancer and Clinical Development of Targeted Anti-MET Agents

od Robinson, Kyle W., Sandler, Alan B.
Izdano 2013

Phase III Clinical Trial Development: A Process of Chutes and Ladders

od Dilts, David M., Cheng, Steven K., Crites, Joshua S., Sandler, Alan B., Doroshow, James H.
Izdano 2010

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4...

od Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Izdano 2010

Prognostic Models to Predict Survival in Non-Small Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab

od Hoang, Tien, Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Izdano 2012

Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501

od Horn, Leora, Dahlberg, Suzanne E., Sandler, Alan B., Dowlati, Afshin, Moore, Dennis F., Murren, John R., Schiller, Joan H.
Izdano 2009

Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer T...

od Sandler, Alan B., Schiller, Joan H., Gray, Robert, Dimery, Isaiah, Brahmer, Julie, Samant, Meghna, Wang, Lisa I., Johnson, David H.
Izdano 2009

Body Mass Index and its Association with Clinical Outcomes for Advanced Non-Small Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

od Dahlberg, Suzanne E., Schiller, Joan H., Bonomi, Philip B., Sandler, Alan B., Brahmer, Julie R., Ramalingam, Suresh S., Johnson, David H.
Izdano 2013

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials

od Langer, Corey J., Socinski, Mark A., Patel, Jyoti D., Sandler, Alan B., Schiller, Joan H., Leon, Larry, Hazard, Sebastien J., Ramalingam, Suresh S.
izdano v Am J Clin Oncol (2016)

Steps and Time to Process Clinical Trials at the Cancer Therapy Evaluation Program

od Dilts, David M., Sandler, Alan B., Cheng, Steven K., Crites, Joshua S., Ferranti, Lori B., Wu, Amy Y., Finnigan, Shanda, Friedman, Steven, Mooney, Margaret, Abrams, Jeffrey
Izdano 2009

Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy

od Moretti, Luigi, Yu, David S., Chen, Heidi, Carbone, David P., Johnson, David H., Keedy, Vicki L., Putnam, Joe B., Sandler, Alan B., Shyr, Yu, Lu, Bo
Izdano 2009

A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas

od Gore, Lia, Rothenberg, Mace L., O'Bryant, Cindy L., Schultz, Mary Kay, Sandler, Alan B., Coffin, Denise, McCoy, Candice, Schott, Astrid, Scholz, Catherine, Eckhardt, S. Gail
Izdano 2008